VBI Vaccines Statistics
Total Valuation
VBI Vaccines has a market cap or net worth of 14,341. The enterprise value is 38.13 million.
Market Cap | 14,341 |
Enterprise Value | 38.13M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
VBI Vaccines has 28.68 million shares outstanding. The number of shares has increased by 127.29% in one year.
Shares Outstanding | 28.68M |
Shares Change (YoY) | +127.29% |
Shares Change (QoQ) | +3.44% |
Owned by Insiders (%) | 0.18% |
Owned by Institutions (%) | 12.87% |
Float | 26.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.00 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.45 |
EV / Sales | 4.05 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.74 |
Financial Position
The company has a current ratio of 0.34
Current Ratio | 0.34 |
Quick Ratio | 0.18 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.99 |
Interest Coverage | -5.84 |
Financial Efficiency
Return on equity (ROE) is -419.59% and return on invested capital (ROIC) is -41.67%.
Return on Equity (ROE) | -419.59% |
Return on Assets (ROA) | -29.15% |
Return on Capital (ROIC) | -41.67% |
Revenue Per Employee | 69,711 |
Profits Per Employee | -622,148 |
Employee Count | 138 |
Asset Turnover | 0.09 |
Inventory Turnover | 1.40 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.92% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -99.92% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.43 |
Relative Strength Index (RSI) | 25.81 |
Average Volume (20 Days) | 138,949 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, VBI Vaccines had revenue of 9.41 million and -83.99 million in losses. Loss per share was -4.30.
Revenue | 9.41M |
Gross Profit | -2.26M |
Operating Income | -47.55M |
Pretax Income | -82.99M |
Net Income | -83.99M |
EBITDA | -45.58M |
EBIT | -47.55M |
Loss Per Share | -4.30 |
Balance Sheet
The company has 12.60 million in cash and 50.71 million in debt, giving a net cash position of -38.12 million or -1.33 per share.
Cash & Cash Equivalents | 12.60M |
Total Debt | 50.71M |
Net Cash | -38.12M |
Net Cash Per Share | -1.33 |
Equity (Book Value) | -5.47M |
Book Value Per Share | -0.22 |
Working Capital | -51.23M |
Cash Flow
In the last 12 months, operating cash flow was -51.00 million and capital expenditures -484,000, giving a free cash flow of -51.48 million.
Operating Cash Flow | -51.00M |
Capital Expenditures | -484,000 |
Free Cash Flow | -51.48M |
FCF Per Share | -1.79 |
Margins
Gross Margin | -24.03% |
Operating Margin | -505.30% |
Pretax Margin | -881.79% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -547.03% |
Dividends & Yields
VBI Vaccines does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -127.29% |
Shareholder Yield | -127.29% |
Earnings Yield | -859,130.40% |
FCF Yield | -358,974.31% |
Stock Splits
The last stock split was on April 12, 2023. It was a reverse split with a ratio of 0.0333333.
Last Split Date | Apr 12, 2023 |
Split Type | Reverse |
Split Ratio | 0.0333333 |
Scores
VBI Vaccines has an Altman Z-Score of -13.76. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.76 |
Piotroski F-Score | n/a |